Company Profile
Statera Biopharma Stock Price, News & Catalysts
- Ticker:
- STAB
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
0.00 USD (0.00%)
Close
Last updated: August 24, 2026
—
Market cap
Why the stock is moving
As of Aug 24, 2026, STAB was little changed and closed at $0.0001. No new same-company headline was identified in the current news window.
Company overview
Business overview
Statera Biopharma was an immunotherapy and inflammation-focused biotechnology company that pursued immune modulation in difficult diseases. Its story was rooted in narrow development programs and the challenge of keeping a micro-cap platform alive.
Geographic Base and Sector Classification
Statera is headquartered in the United States and listed on NASDAQ. It sits in small-cap immunology biotechnology.
Business Model Characteristics
The company depended on clinical progress, restructuring, and capital preservation. Investors historically watched whether the platform could generate enough data to justify continued development.
Position Within the Biotechnology Landscape
Statera occupies a historical micro-cap immunology niche within biotech. The stock was always highly sensitive to financing and program-level updates.
Future catalysts
- Statera is a legacy / closeout story, with catalysts limited to any remaining strategic or asset-resolution update. There is no active standalone growth story left.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Statera Biopharma (STAB)?
Statera Biopharma (STAB) most recently closed at 0.00 USD, a 0.00% move versus the previous session.
What does Statera Biopharma do?
Statera Biopharma was an immunotherapy and inflammation-focused biotechnology company that pursued immune modulation in difficult diseases. Its story was rooted in narrow development programs and the challenge of keeping a micro-cap platform alive.
On which exchange is STAB stock listed?
Statera Biopharma (STAB) is associated with NASDAQ, United States, Biopharma.
What is Statera?
Statera is a legacy / closeout story, with catalysts limited to any remaining strategic or asset-resolution update.
Which conditions is Statera Biopharma targeting with Statera?
Statera Biopharma is associated with inflammatory disease based on its company overview and current catalyst commentary.
How does Statera Biopharma describe recent progress with Statera?
Statera is a legacy / closeout story, with catalysts limited to any remaining strategic or asset-resolution update.
What is Biopharma?
Statera Biopharma was an immunotherapy and inflammation-focused biotechnology company that pursued immune modulation in difficult diseases.
What should investors watch for with Biopharma?
Statera is a legacy / closeout story, with catalysts limited to any remaining strategic or asset-resolution update. There is no active standalone growth story left.